Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Xu

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Cancer Research|December 1, 1992
Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067B H Xu, S V Singh
Archives of Biochemistry and Biophysics|January 1, 1994
Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistanceB H Xu, V Gupta, S V Singh
International Journal of Cancer|September 1, 1994
Characterization of a human bladder cancer cell line selected for resistance to mitomycin CB H Xu, V Gupta, S V Singh
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2016
[Chinese expert consensus on the diagnosis and treatment of breast carcinoma in situ]Q Sun, B H Xu, Z M Shao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 28, 2016
[Clinicopathological features and prognosis of HER2-negative luminal-type breast cancer patients with early and late recurrence]X L Chen, Y Fan, B H Xu
European Review for Medical and Pharmacological Sciences|December 18, 2018
A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancerZ Li, Z-M Liu, B-H Xu
British Journal of Cancer|February 1, 1994
Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogueB H Xu, V Gupta, S V Singh
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 26, 2019
[Comprehensive management guideline for breast cancer follow-up and concomitant diseases]F Ma, B H Xu, Z M Shao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 21, 2017
[The treatment and prognosis of peripheral primitive neuroectodermal tumor]B Lan, L Wang, B H Xu, et al.
Die Pharmazie|October 27, 2011
Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbinO Mezghrani, X Ke, N Bourkaib, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Cancer Research|December 1, 1992
Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067B H Xu, S V Singh
Archives of Biochemistry and Biophysics|January 1, 1994
Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistanceB H Xu, V Gupta, S V Singh
International Journal of Cancer|September 1, 1994
Characterization of a human bladder cancer cell line selected for resistance to mitomycin CB H Xu, V Gupta, S V Singh
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2016
[Chinese expert consensus on the diagnosis and treatment of breast carcinoma in situ]Q Sun, B H Xu, Z M Shao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 28, 2016
[Clinicopathological features and prognosis of HER2-negative luminal-type breast cancer patients with early and late recurrence]X L Chen, Y Fan, B H Xu
European Review for Medical and Pharmacological Sciences|December 18, 2018
A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancerZ Li, Z-M Liu, B-H Xu
British Journal of Cancer|February 1, 1994
Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogueB H Xu, V Gupta, S V Singh
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 26, 2019
[Comprehensive management guideline for breast cancer follow-up and concomitant diseases]F Ma, B H Xu, Z M Shao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 21, 2017
[The treatment and prognosis of peripheral primitive neuroectodermal tumor]B Lan, L Wang, B H Xu, et al.
Die Pharmazie|October 27, 2011
Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbinO Mezghrani, X Ke, N Bourkaib, et al.
Pageof 7